返回
Onconetix Inc（ONCO）价格
ONCO 股价走势图
ONCO 收益
Onconetix Inc
$1.62
0.93%
$0.01
收盘价：Jan 16, 16:00:00 GMT-5
$1.55
-4.61%
$-0.07
盘后：Jan 16, 20:00:00 GMT-5
关键数据
前收盘价
$1.61
开盘价
$1.6
当日区间
$1.48 - $1.63
52周范围
$1.37 - $88.4
交易量
10.8K
平均成交量
41.8K
每股收益（TTM）
-342.64
股息收益率
--
市值
$2.4M
什么是 ONCO？
Onconetix, Inc. is a commercial stage biotechnology company, which engages in the research, development and commercialization of proprietary therapeutics, diagnostics and services for clinicians and patients for oncology. The company is headquartered in Cincinnati, Ohio and currently employs 5 full-time employees. The company went IPO on 2022-02-18. The firm owns Proclarix, an in vitro diagnostic test for prostate cancer approved for sale in the European Union under the In Vitro Diagnostic Regulation. Proclarix is an easy-to-use next generation protein-based blood test that can be done with the same sample as a patient’s regular Prostate-Specific Antigen (PSA) test.